<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>LENUS Collection:</title>
    <link>http://hdl.handle.net/10147/145229</link>
    <description />
    <pubDate>Fri, 24 May 2013 21:11:22 GMT</pubDate>
    <dc:date>2013-05-24T21:11:22Z</dc:date>
    <image>
      <title>LENUS Collection:</title>
      <url>http://www.lenus.ie:80/hse/retrieve/318229/icsLogo7.gif</url>
      <link>http://hdl.handle.net/10147/145229</link>
    </image>
    <item>
      <title>Cancers of the head neck and mouth</title>
      <link>http://hdl.handle.net/10147/292544</link>
      <description>Title: Cancers of the head neck and mouth
Authors: Irish Cancer Society
Description: Booklet</description>
      <pubDate>Sun, 01 Jan 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/292544</guid>
      <dc:date>2012-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>An oral cancer screening study of high risk individuals</title>
      <link>http://hdl.handle.net/10147/240878</link>
      <description>Title: An oral cancer screening study of high risk individuals
Authors: O'Sullivan, Eleanor
Description: This study indicates that an Oral Cancer Screening programme targeted at high risk 1nd1viduals&#xD;
1s feasible, acceptable and effect1ve. In a senes of 210 residents, 60% of whom were outside&#xD;
the ideal target age for Head and Neck Cancer, a total of 84 mucosal abnormalities were&#xD;
detected. Thirteen of the 28 Extra-Oral Lesions/ENT symptoms and 19 of the 56 Intra-Oral&#xD;
lesions were potentially significant. Despite the poor compliance rate for further investigation,&#xD;
two premalignant les1ons were detected in the mam study group, a detect1on rate of 0.9%.&#xD;
Furthermore, a malignant Basal Cell Cancer, which had 1nvaded mto deep dermis. was detected in&#xD;
the sub-group excluded from the main study. If these residents are included, the detection rate for&#xD;
malignant and premalignant lesions rises to 1.3% (3/220).</description>
      <pubDate>Tue, 01 Jan 2008 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/240878</guid>
      <dc:date>2008-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>An investigation into the provision, fitting and supply of external breast prostheses: a national study</title>
      <link>http://hdl.handle.net/10147/188329</link>
      <description>Title: An investigation into the provision, fitting and supply of external breast prostheses: a national study
Authors: Gallagher, Pamela; O'Carroll, Susan; Buckmaster, Ann; Mathers, Rachel; Kiernan, Gemma; Geraghty, James
Description: Breast Cancer is one of the most common cancers affecting women in Ireland with approximately&#xD;
1,726 women being registered with breast cancer each year (National Cancer Registry Ireland (NCRI),&#xD;
2005). The majority of women with breast cancer have surgery as a form of treatment either on its&#xD;
own or in combination with radiotherapy, chemotherapy and/or hormone therapy (NCRI, 2005). An&#xD;
integral part of the recovery post surgery involves considering restorative options. For many women in&#xD;
Ireland this means being fitted with an external breast prosthesis. Currently, there are an estimated&#xD;
16,000 women in Ireland who have undergone a mastectomy and require an external breast&#xD;
prosthesis. The overall purpose of this research is to gain an insight into women’s experience of the&#xD;
provision, fitting, supply and use of external breast prostheses in Ireland.</description>
      <pubDate>Wed, 01 Nov 2006 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/188329</guid>
      <dc:date>2006-11-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The financial impact of a cancer diagnosis</title>
      <link>http://hdl.handle.net/10147/188292</link>
      <description>Title: The financial impact of a cancer diagnosis
Authors: Sharp, Linda; Timmons, Aileen
Description: The costs to the health services of the diagnosis and treatment of cancer are substantial.&#xD;
These costs have increased over the past decades and are expected to rise further in&#xD;
coming years with population ageing and advances in treatment. However, the economic&#xD;
burden of cancer does not fall only on the health services, but also on patients, their&#xD;
families, and society as a whole. Until recently, little has been known about the costs&#xD;
incurred by cancer patients and their families.&#xD;
This project set out to answer the following questions:&#xD;
• What are the main elements of additional cost (medical and non-medical) incurred by&#xD;
cancer patients and their families?&#xD;
• How much additional expense do patients incur as a result of their diagnosis with&#xD;
cancer?&#xD;
• What impact does cancer have on income (e.g. lost pay, availability of sick pay, access&#xD;
to benefits)?&#xD;
• What proportion of patients (a) incur additional costs or (b) experience financial&#xD;
difficulties as a result of their cancer diagnosis?&#xD;
• Are particular groups of patients more vulnerable to incurring additional costs or&#xD;
financial difficulties as a result of having cancer?&#xD;
• What are the consequences of the additional expenses, and any changes in income, for&#xD;
patients and their families?</description>
      <pubDate>Fri, 01 Jan 2010 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/188292</guid>
      <dc:date>2010-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

